Mickle Travis C 13D/13G Filings for Zevra Therapeutics, Inc. (ZVRA)

Mickle Travis C 13D and 13G filings for Zevra Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-11
8:14 pm
Purchase
2020-12-3113GZevra Therapeutics, Inc.
ZVRA
Mickle Travis C227,545
4.900%
227,545increase
(New Position)
Filing